A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation

Ankshita Prasad, Janani Manivannan, Daniel T B Loong, Soo M. Chua, Payam Mohammadgharibani, Angelo Homayoun All

Research output: Contribution to journalArticle

Abstract

Rapid progress in the field of stem cell therapy and cellular reprogramming provides convincing evidence of its feasibility in treating a wide range of pathologies through autologous cell replacement therapy. This review article describes in detail on three widely used approaches of somatic cell reprogramming: induced pluripotent stem cells, direct conversion and direct reprogramming, in the context of demyelination in the CNS. The potential limitations of each reprogramming technique are reviewed along with their distinct molecular approach to reprogramming. This is followed by an analysis on the scopes and challenges of its translational applications in deriving oligodendrocyte progenitor cells and oligodendrocytes for cell replacement treatment of demyelinating conditions in the CNS.

Original languageEnglish (US)
Pages (from-to)181-191
Number of pages11
JournalRegenerative Medicine
Volume11
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Induced Pluripotent Stem Cells
Oligodendroglia
Stem cells
Cell- and Tissue-Based Therapy
Pathology
Stem Cells
Demyelinating Diseases
Cellular Reprogramming
Therapeutics

Keywords

  • direct conversion
  • direct reprogramming
  • iPSC reprogramming
  • oligodendrocytes
  • transdifferentiation

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation. / Prasad, Ankshita; Manivannan, Janani; Loong, Daniel T B; Chua, Soo M.; Mohammadgharibani, Payam; All, Angelo Homayoun.

In: Regenerative Medicine, Vol. 11, No. 2, 01.03.2016, p. 181-191.

Research output: Contribution to journalArticle

@article{90a08fe97576485288bd43308beea714,
title = "A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation",
abstract = "Rapid progress in the field of stem cell therapy and cellular reprogramming provides convincing evidence of its feasibility in treating a wide range of pathologies through autologous cell replacement therapy. This review article describes in detail on three widely used approaches of somatic cell reprogramming: induced pluripotent stem cells, direct conversion and direct reprogramming, in the context of demyelination in the CNS. The potential limitations of each reprogramming technique are reviewed along with their distinct molecular approach to reprogramming. This is followed by an analysis on the scopes and challenges of its translational applications in deriving oligodendrocyte progenitor cells and oligodendrocytes for cell replacement treatment of demyelinating conditions in the CNS.",
keywords = "direct conversion, direct reprogramming, iPSC reprogramming, oligodendrocytes, transdifferentiation",
author = "Ankshita Prasad and Janani Manivannan and Loong, {Daniel T B} and Chua, {Soo M.} and Payam Mohammadgharibani and All, {Angelo Homayoun}",
year = "2016",
month = "3",
day = "1",
doi = "10.2217/rme.16.5",
language = "English (US)",
volume = "11",
pages = "181--191",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation

AU - Prasad, Ankshita

AU - Manivannan, Janani

AU - Loong, Daniel T B

AU - Chua, Soo M.

AU - Mohammadgharibani, Payam

AU - All, Angelo Homayoun

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Rapid progress in the field of stem cell therapy and cellular reprogramming provides convincing evidence of its feasibility in treating a wide range of pathologies through autologous cell replacement therapy. This review article describes in detail on three widely used approaches of somatic cell reprogramming: induced pluripotent stem cells, direct conversion and direct reprogramming, in the context of demyelination in the CNS. The potential limitations of each reprogramming technique are reviewed along with their distinct molecular approach to reprogramming. This is followed by an analysis on the scopes and challenges of its translational applications in deriving oligodendrocyte progenitor cells and oligodendrocytes for cell replacement treatment of demyelinating conditions in the CNS.

AB - Rapid progress in the field of stem cell therapy and cellular reprogramming provides convincing evidence of its feasibility in treating a wide range of pathologies through autologous cell replacement therapy. This review article describes in detail on three widely used approaches of somatic cell reprogramming: induced pluripotent stem cells, direct conversion and direct reprogramming, in the context of demyelination in the CNS. The potential limitations of each reprogramming technique are reviewed along with their distinct molecular approach to reprogramming. This is followed by an analysis on the scopes and challenges of its translational applications in deriving oligodendrocyte progenitor cells and oligodendrocytes for cell replacement treatment of demyelinating conditions in the CNS.

KW - direct conversion

KW - direct reprogramming

KW - iPSC reprogramming

KW - oligodendrocytes

KW - transdifferentiation

UR - http://www.scopus.com/inward/record.url?scp=84962331254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962331254&partnerID=8YFLogxK

U2 - 10.2217/rme.16.5

DO - 10.2217/rme.16.5

M3 - Article

C2 - 26857809

AN - SCOPUS:84962331254

VL - 11

SP - 181

EP - 191

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 2

ER -